# REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial

Study · id `cardio:ct-nct02499822` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02499822](<https://clinicaltrials.gov/study/NCT02499822>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02499822

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 168 participants.

## Technical summary

Registry record NCT02499822. Randomized; single masking; primary purpose treatment. Start 2015-10 (registry gives no type); primary completion 2020-07-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 168 participants (enrolled count; ClinicalTrials.gov record NCT02499822, source copy `cardio:ctgov-nct02499822-2021-09-30`, retrieved 2026-10-26)
- Start date: 2015-10 (registry gives no type) (ClinicalTrials.gov record NCT02499822, source copy `cardio:ctgov-nct02499822-2021-09-30`, retrieved 2026-10-26)
- Primary completion: 2020-07-03 (actual) (ClinicalTrials.gov record NCT02499822, source copy `cardio:ctgov-nct02499822-2021-09-30`, retrieved 2026-10-26)
- Completion: 2020-11-01 (actual) (ClinicalTrials.gov record NCT02499822, source copy `cardio:ctgov-nct02499822-2021-09-30`, retrieved 2026-10-26)
- Countries: China; Greece; Italy (ClinicalTrials.gov record NCT02499822, source copy `cardio:ctgov-nct02499822-2021-09-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02499822-2021-09-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial
- Acronym: REVERENT
- Condition: Hypertension
- Condition: High Blood Pressure Variability
- Intervention (Drug): Nifedipine GITS
- Intervention (Drug): Ramipril
- Lead sponsor: Istituto Auxologico Italiano
- Lead sponsor class: OTHER
- Collaborator: Bayer
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Ramipril (`cardio:ramipril`)
- Registry lists this organization as the lead sponsor: Istituto Auxologico Italiano (`cardio:org-istituto-auxologico-italiano`)
- Registry lists this organization as a collaborator: Bayer (`cardio:bayer`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A Randomized Controlled Trial on the Efficacy and Safety of a Calcium-Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor in Chinese and European Patients with Hypertension (`cardio:pubmed-39657776`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3c3abc25504778dcd2bada7c57850e6cddcbfced77dde17be21d8f2ce14c71ec
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
